Connection
Kevin Lillehei to Antibodies, Monoclonal
This is a "connection" page, showing publications Kevin Lillehei has written about Antibodies, Monoclonal.
|
|
Connection Strength |
|
![](https://profiles.ucdenver.edu/Framework/Images/connection_left.gif) |
|
![](https://profiles.ucdenver.edu/Framework/Images/connection_right.gif) |
|
0.027 |
|
|
|
-
Kleinschmidt-DeMasters BK, Damek DM, Lillehei KO, Dogan A, Giannini C. Epstein Barr virus-associated primary CNS lymphomas in elderly patients on immunosuppressive medications. J Neuropathol Exp Neurol. 2008 Nov; 67(11):1103-11.
Score: 0.013
-
Kleinschmidt-DeMasters BK, Hashizumi TL, Sze CI, Lillehei KO, Shroyer AL, Shroyer KR. Telomerase expression shows differences across multiple regions of oligodendroglioma versus high grade astrocytomas but shows correlation with Mib-1 labelling. J Clin Pathol. 1998 Apr; 51(4):284-93.
Score: 0.006
-
Kleinschmidt-DeMasters BK, Conway DR, Franklin WA, Lillehei KO, Kruse CA. Neural cell adhesion molecule expression in human pituitary adenomas. J Neurooncol. 1995; 25(3):205-13.
Score: 0.005
-
Kruse CA, Mitchell DH, Lillehei KO, Johnson SD, McCleary EL, Moore GE, Waldrop S, Mierau GW. Interleukin-2-activated lymphocytes from brain tumor patients. A comparison of two preparations generated in vitro. Cancer. 1989 Oct 15; 64(8):1629-37.
Score: 0.003